Your browser doesn't support javascript.
loading
RNF8 ubiquitylation of XRN2 facilitates R-loop resolution and restrains genomic instability in BRCA1 mutant cells.
Krishnan, Rehna; Lapierre, Mariah; Gautreau, Brandon; Nixon, Kevin C J; El Ghamrasni, Samah; Patel, Parasvi S; Hao, Jun; Yerlici, V Talya; Guturi, Kiran Kumar Naidu; St-Germain, Jonathan; Mateo, Francesca; Saad, Amine; Algouneh, Arash; Earnshaw, Rebecca; Shili, Duan; Seitova, Alma; Miller, Joshua; Khosraviani, Negin; Penn, Adam; Ho, Brandon; Sanchez, Otto; Hande, M Prakash; Masson, Jean-Yves; Brown, Grant W; Alaoui-Jamali, Moulay; Reynolds, John J; Arrowsmith, Cheryl; Raught, Brian; Pujana, Miguel A; Mekhail, Karim; Stewart, Grant S; Hakem, Anne; Hakem, Razqallah.
Afiliación
  • Krishnan R; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 1L7, Canada.
  • Lapierre M; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 1L7, Canada.
  • Gautreau B; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
  • Nixon KCJ; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 1L7, Canada.
  • El Ghamrasni S; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
  • Patel PS; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 1L7, Canada.
  • Hao J; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 1L7, Canada.
  • Yerlici VT; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 1L7, Canada.
  • Guturi KKN; Department of Medical Biophysics, University of Toronto, Ontario M5G 1L7, Canada.
  • St-Germain J; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 1L7, Canada.
  • Mateo F; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
  • Saad A; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 1L7, Canada.
  • Algouneh A; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 1L7, Canada.
  • Earnshaw R; Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona 08908, Catalonia, Spain.
  • Shili D; Segal Cancer Centre and Lady Davis Institute for Medical Research, Departments of Medicine and Oncology, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.
  • Seitova A; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 1L7, Canada.
  • Miller J; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 1L7, Canada.
  • Khosraviani N; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 1L7, Canada.
  • Penn A; Structural Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7, Canada.
  • Ho B; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 1L7, Canada.
  • Sanchez O; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
  • Hande MP; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 1L7, Canada.
  • Masson JY; Department of Biochemistry and Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
  • Brown GW; Ontario Tech University, 2000 Simcoe Street North Oshawa, Ontario L1G 0C5, Canada.
  • Alaoui-Jamali M; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Reynolds JJ; Genome Stability Laboratory, CHU de Québec Research Center, Oncology Axis; Department of Molecular Biology, Medical Biochemistry and Pathology; Laval University Cancer Research Center, 9 McMahon, Québec City, Québec G1R 2J6, Canada.
  • Arrowsmith C; Department of Biochemistry and Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
  • Raught B; Segal Cancer Centre and Lady Davis Institute for Medical Research, Departments of Medicine and Oncology, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.
  • Pujana MA; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Mekhail K; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 1L7, Canada.
  • Stewart GS; Department of Medical Biophysics, University of Toronto, Ontario M5G 1L7, Canada.
  • Hakem A; Structural Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7, Canada.
  • Hakem R; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 1L7, Canada.
Nucleic Acids Res ; 51(19): 10484-10505, 2023 10 27.
Article en En | MEDLINE | ID: mdl-37697435
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Proteína BRCA1 Límite: Animals / Female / Humans Idioma: En Revista: Nucleic Acids Res Año: 2023 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Proteína BRCA1 Límite: Animals / Female / Humans Idioma: En Revista: Nucleic Acids Res Año: 2023 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido